Larry Ellison bankrolling £118M vaccine research at Oxford
4 Articles
4 Articles
Oracle’s billionaire president’s technology institute, Larry Ellison, will fund a pioneering project that uses artificial intelligence for the research of...
Oxford secures £118m for AI-driven vaccine research with Ellison Institute
The University of Oxford has launched a £118m AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials A new initiative, led by Oxford Vaccine Group, named CoI-AI (Correlates of Immunity-Artificial Intelligence), will combine Oxford’s expertise in human challenge studies, immune science, and vaccine development with the Ellison Institute of Technology (EIT)’s Artific…
Larry Ellison bankrolling £118M AI vaccine research at Oxford University
Oracle billionaire funds project to predict immunity and develop treatments for hard-to-prevent diseases A research group funded by tech billionaire Larry Ellison is set to invest £118 million ($169.6 million) in applying AI to vaccine research with the UK's Oxford University. . . .
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium